Wednesday, January 18, 2012
January 20, 2012 - Pacifier Activated Lullabies
Today my guest is Kathy Lovell, who will talk about the Pacifer Activated Lullaby technology.
The PAL® technology is based on research conducted at the Florida State University by Dr. Jayne Standley. An FSU faculty member since 1976, Dr. Standley is recognized throughout the United States as the foremost authority on medical music therapy. Researching the effect of music on premature babies, she found they increased their sucking rates 2.5 times when exposed to music, thus helping to increase their weight. Aimed specifically at addressing a long-standing problem among premature infants – delayed proficiencies in learning to suck – Dr. Standley’ s musical pacifier has demonstrated what have been called “amazing” results in repeated tests done at Tallahassee Memorial Hospital.
Listen LIVE at Noon Eastern, 11 am Central, 10 am Mountain, 9 am Pacific or check out the archived show. You can also subscribe in iTunes.
“. . . . after more than 100 years of study on this topic, a body of knowledge now exists to document the many medical, social, and emotional benefits of music.” 2003 – Jayne Standley, Ph.D.
Biography – P. Kathleen (Kathy) Lovell
Kathy is the Chief Executive Officer of Powers Device Technologies, Inc. She has more than 25 years of management, sales, marketing, financial, manufacturing, and operational experience. Her focus is building high-growth entrepreneurial ventures by helping early-stage companies refine their business models, develop their infrastructure, access capital and attain profitability. Kathy is Chairman of the Emergent Growth Funds, LLC in Gainesville, FL. Emergent Growth Funds I and II are member-managed angel funds, focusing on early stage companies developing unique, leading-edge products, or proprietary technologies that possess the potential for rapid growth in significant markets. Emergent is fully funded by its members and makes direct investments in its portfolio companies. Kathy serves on the boards of directors for AerovectRx Corporation, Atlanta, GA and Wilmington Pharmaceuticals, Inc., Wilmington, NC (both Emergent Growth portfolio companies.)
Prior to assuming the role of CEO at Powers Device Technologies, Inc., Kathy held executive-level marketing, sales and operations positions with several technology companies. Her manufacturing experience includes over 13 years with Bristol-Myers Squibb. Kathy holds a B.S. in Economics and Business Administration from State University of New York. She attended Springfield College, Masters of Education program and is currently enrolled in Nova Southeastern’s Masters of Accountancy program.